港股異動丨友邦(1299.HK)大漲近4% 貢獻恆指逾90點
格隆匯8月4日丨友邦(1299.HK)大漲近4%,報72.05港元,總市值8712億港元,其貢獻恆指逾90點,恆指現漲逾2%,報24987點。中金髮表研究報告稱,目前公司業務在近期面臨的形勢為長線投資者提供了更好的入場機會,因此予以目標價95港元及“跑贏行業”評級。瑞信發表研究報告稱,瑞信維持公司目標價82港元及“跑贏大市”評級。瑞信表示,如果公共衞生事件能夠按照預期恢復,預計公司上半年的內涵價值(EV)將達到620億美元;因此瑞信建議投資者認真考慮公司未來的發展策略,尤其是內地市場的表現對友邦保險的成功與否非常重要。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.